Profil
Marc Pierre Jean Dunoyer est directeur financier et directeur exécutif d'AstraZeneca Plc et siège au conseil d'administration de 5 autres sociétés. Il a précédemment occupé le poste de Global Head-Rare Diseases Unit chez GlaxoSmithKline Plc et de Président de GlaxoSmithKline KK (une filiale de GlaxoSmithKline Plc) et Président-Asie Pacifique chez Hoechst Marion Roussel SA. Il est titulaire d'un MBA des Hautes Etudes Commerciales et d'un diplôme d'études supérieures de l'Université de Paris IV Paris-Sorbonne.
Dernières actualités sur Marc Dunoyer
Postes actifs de Marc Dunoyer
| Sociétés | Poste | Début |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/08/2021 |
| ALEXION PHARMACEUTICALS, INC. | Directeur Général | - |
| CELLECTIS S.A. | Directeur/Membre du Conseil | 06/05/2024 |
| JCR PHARMACEUTICALS CO., LTD. | Directeur/Membre du Conseil | 01/06/2023 |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Directeur/Membre du Conseil | 29/11/2013 |
Alexion Pharmaceuticals, Inc. /New/ | Directeur Général | 01/08/2021 |
AstraZeneca KK
AstraZeneca KK Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medical drugs | Président | - |
Astrazeneca Intermediate Holdings Ltd.
Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as an intermediate holding company through its subsidiaries researches, manufactures and markets pharmaceuticals | Directeur/Membre du Conseil | - |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Directeur/Membre du Conseil | 07/06/2018 |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Marc Dunoyer
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Marc Dunoyer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Hoechst Marion Roussel SA
Hoechst Marion Roussel SA Pharmaceuticals: OtherHealth Technology Medicinal chemicals and botanical products | Health Technology |
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
GlaxoSmithKline KK
GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables Researches, develops, imports, manufactures and sells toiletry products | Consumer Non-Durables |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
JCR Pharmaceuticals Co., Ltd.
JCR Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells ethical drugs and regenerative medicine | Health Technology |
Hautes Etudes Commerciales
Hautes Etudes Commerciales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectis SA
Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Commercial Services |
AstraZeneca KK
AstraZeneca KK Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medical drugs | Health Technology |
Astrazeneca Intermediate Holdings Ltd.
Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as an intermediate holding company through its subsidiaries researches, manufactures and markets pharmaceuticals | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Alexion Pharmaceuticals, Inc. /New/ | |
Paris University of
Paris University of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















